Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Summary

To evaluate the efficacy and safety of combination of anticoagulant and antiplatelet therapy on the patency of iliac vein at 12-month post stenting in patients with acute proximal DVT and ipsilateral iliac vein stenosis who received percutaneous mechanic thrombectomy and iliac vein stenting.

Conditions

• Deep Vein Thrombosis
• Iliac Vein Thrombosis
• Iliac Vein Obstruction
• Iliac Vein Stenosis
• Iliac Vein Compression Syndrome

Interventions

DRUG

Rivaroxaban

For anticoagulant, it is rivaroxaban 20mg once a day for 6 months.

DRUG

Aspirin

For antiplatelet therapy, it is aspirin 100mg once a day indefinitely.

Sponsors & Collaborators

• Zhejiang University

  collaborator OTHER

• Ningbo No.2 Hospital

  collaborator OTHER

• Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

  collaborator OTHER

• The Central Hospital of Lishui City

  collaborator OTHER

• Taizhou Enze Medical Center Group

  collaborator OTHER

• Taizhou First People's Hospital

  collaborator OTHER

• Boston Scientific Corporation

  collaborator INDUSTRY

• First Affiliated Hospital of Zhejiang University

  lead OTHER

Principal Investigators

• Hongkun Zhang, M.D. · First Affiliated Hospital of Zhejiang University

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-11-03

Primary Completion

2026-12-31

Completion

2027-06-30

Countries

• China

Study Locations